表紙
市場調查報告書

泌尿科的日本市場:分析、規模、趨勢

Urology Market Analysis, Size, Trends | Japan | MedSuite

出版商 iData Research Inc. 商品編碼 918708
出版日期 內容資訊 英文 393 Pages
商品交期: 最快1-2個工作天內
價格
泌尿科的日本市場:分析、規模、趨勢 Urology Market Analysis, Size, Trends | Japan | MedSuite
出版日期: 2019年11月08日內容資訊: 英文 393 Pages
簡介

本報告提供日本的泌尿科市場相關調查分析,疾病概要,市場分析與預測,產品系列等相關的系統性資訊。

摘要整理

日本的泌尿科用設備市場概要

競爭分析

市場趨勢

市場發展

治療數量

對象市場

主要的調查更新

版本履歷

第1章 調查手法

第2章 疾病概要

  • 基本結構
  • 疾病的治療和診斷
  • 患者人口統計

第3章 產品的評估

  • 簡介
  • 產品系列
    • 尿失禁
    • 骨盆器官脫垂修復
    • 結石管理
    • 前列腺肥大症 (BPH) 治療
    • 勃起功能障礙 (ED)
  • 法規問題和回收
  • 臨床實驗

第4章 日本的泌尿科用設備市場概要

  • 簡介
  • 貨幣匯率
  • 市場概要
  • 趨勢分析:各市場區隔
  • 促進因素、阻礙因素
  • 競爭市場佔有率分析
  • M&A
  • 企業簡介
  • SWOT分析

第5章 治療數量

  • 治療概要
  • 尿失禁
  • 骨盆器官脫垂修復
  • 結石管理
  • 前列腺肥大症 (BPH) 治療
  • 勃起功能障礙 (ED)

第6章 尿失禁用設備市場

  • 簡介
  • 市場概要
  • 市場分析、預測
  • 促進因素、阻礙因素
  • 競爭市場佔有率分析

第7章 骨盆器官脫垂修複用設備市場

第8章 結石管理用設備市場

第9章 前列腺肥大症 (BPH) 治療用設備市場

第10章 勃起功能障礙 (ED) 用設備市場

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: iDATA_JPUR20_MS

The full report suite on the Japanese market for urological devices includes urinary incontinence management devices, pelvic organ prolapse repair, stone management devices, benign prostate hyperplasia (BPH) treatment devices and erectile dysfunction devices.

The healthcare system in Japan was established as the universal health insurance scheme in 1961, according to which citizens can access medical services for a relatively low co-payment. Over the last decades, the rapidly-growing aging population combined with the decrease in the working population have caused financial difficulty. These also resulted in structural reform in healthcare, due to higher prevalence of chronic and age-related conditions.

TABLE OF CONTENTS

TABLE OF CONTENTS I

LIST OF FIGURES X

LIST OF CHARTS XIX

EXECUTIVE SUMMARY 1

JAPAN UROLOGICAL DEVICES MARKET OVERVIEW 1

COMPETITIVE ANALYSIS 3

MARKET TRENDS 5

MARKET DEVELOPMENTS 6

PROCEDURE NUMBERS 8

MARKETS INCLUDED 9

KEY REPORT UPDATES 11

VERSION HISTORY 11

RESEARCH METHODOLOGY 12

  • Step 1: Project Initiation & Team Selection 12
  • Step 2: Prepare Data Systems and Perform Secondary Research 15
  • Step 3: Preparation for Interviews & Questionnaire Design 17
  • Step 4: Performing Primary Research 18
  • Step 5: Research Analysis: Establishing Baseline Estimates 20
  • Step 6: Market Forecast and Analysis 21
  • Step 7: Identify Strategic Opportunities 23
  • Step 8: Final Review and Market Release 24
  • Step 9: Customer Feedback and Market Monitoring 25

DISEASE OVERVIEW 26

  • 2.1 BASIC ANATOMY 26
    • 2.1.1 Urinary System 26
      • 2.1.1.1 Male Urinary System 27
      • 2.1.1.2 Female Urinary System 28
  • 2.2 DISEASE TREATMENT AND DIAGNOSTICS 29
    • 2.2.1 Benign Prostatic Hyperplasia 29
    • 2.2.2 Urinary Incontinence 31
    • 2.2.3 Urinary Tract Infections 33
    • 2.2.4 Kidney Stones 34
    • 2.2.5 Bladder Prolapse 36
    • 2.2.6 Overactive Bladder 37
    • 2.2.7 Prostatitis 38
    • 2.2.8 Erectile Dysfunction 40
    • 2.2.9 Cancer 42
      • 2.2.9.1 Prostate Cancer 42
      • 2.2.9.2 Bladder Cancer 43
    • 2.2.10 Indications for Pelvic Organ Prolapse Repair 45

PRODUCT ASSESSMENT 46

  • 3.1 INTRODUCTION 46
  • 3.2 PRODUCT PORTFOLIOS 46
    • 3.2.1 Urinary Incontinence 46
      • 3.2.1.1 Urinary Catheters 46
      • 3.2.1.1.1 Intermittent Catheters 46
      • 3.2.1.1.2 Foley Catheters 47
      • 3.2.1.1.3 Male External Catheters 48
      • 3.2.1.2 Urethral Bulking Agents 49
      • 3.2.1.3 Incontinence Management Devices 50
      • 3.2.1.3.1 Female Incontinence Slings 50
      • 3.2.1.3.2 Male Implantable Devices 51
      • 3.2.1.4 Urine Bags 53
      • 3.2.1.4.1 Leg Bags 53
      • 3.2.1.4.2 Night Bags 53
    • 3.2.2 Pelvic Organ Prolapse Repair 58
      • 3.2.2.1 Autologous tissue as an alternative to vaginal mesh 59
      • 3.2.2.2 Product Matrix for Pelvic Organ Prolapse Repair 60
    • 3.2.3 Stone Management 61
      • 3.2.3.1 ESWL Equipment 61
      • 3.2.3.2 ISWL Equipment 62
      • 3.2.3.3 Holmium Lasers 62
      • 3.2.3.4 Stone Fragment Retrieval Devices 63
      • 3.2.3.5 Ureteral Stents 63
    • 3.2.4 BPH Treatment 67
      • 3.2.4.1 TURP 67
      • 3.2.4.2 TUMT 68
      • 3.2.4.3 TUNA 68
      • 3.2.4.4 Prostatic Stents 69
      • 3.2.4.5 Laser BPH 70
      • 3.2.4.5.1 Photoselective Vaporization of the Prostate (PVP) 71
      • 3.2.4.5.2 Laser Vaporization of the Prostate 72
      • 3.2.4.5.3 Laser Ablation of the Prostate 73
      • 3.2.4.5.4 Laser Resection of the Prostate 73
      • 3.2.4.5.5 Laser Enucleation of the Prostate 74
    • 3.2.5 Erectile Dysfunction 76
      • 3.2.5.1 Penile Implants 76
      • 3.2.5.1.1 Inflatable 76
      • 3.2.5.1.2 Malleable 77
      • 3.2.5.2 Vacuum 77
  • 3.3 REGULATORY ISSUES AND RECALLS 79
    • 3.3.1 Boston Scientific 79
      • 3.3.1.1 Stone Management 79
      • 3.3.1.2 Nephrostomy 81
    • 3.3.2 C. R. Bard (Becton Dickinson) 82
      • 3.3.2.1 Urinary Incontinence 82
      • 3.3.2.2 Stone Management 87
      • 3.3.2.3 Urological Endoscopes 87
      • 3.3.2.4 Prostate Cancer Treatment 87
      • 3.3.2.5 Nephrostomy 88
    • 3.3.3 Coloplast 90
      • 3.3.3.1 Urinary Catheter 90
      • 3.3.3.2 Erectile Dysfunction 90
    • 3.3.4 Cook Medical 91
      • 3.3.4.1 Stone Management 91
      • 3.3.4.2 Nephrostomy 92
    • 3.3.5 Elekta 94
      • 3.3.5.1 Prostate Cancer Treatment 94
    • 3.3.6 Karl Storz 95
      • 3.3.6.1 Urological Endoscopes 95
    • 3.3.7 Olympus 96
      • 3.3.7.1 Urological Endoscopes 96
  • 3.4 CLINICAL TRIALS 98
    • 3.4.1 Boston Scientific 98
      • 3.4.1.1 Urinary Incontinence 98
      • 3.4.1.2 BPH Treatment 99
      • 3.4.1.3 Urological endoscopes 100
      • 3.4.1.4 Nephrostomy 101
      • 3.4.1.5 Erectile Dysfunction 102
    • 3.4.2 C. R. Bard (Becton Dickinson) 103
      • 3.4.2.1 Urinary Incontinence 103
      • 3.4.2.2 Prostate Cancer Treatment 105
    • 3.4.3 Coloplast 106
      • 3.4.3.1 Urinary Incontinence 106
    • 3.4.4 Cook Medical 109
      • 3.4.4.1 Nephrostomy 109
    • 3.4.5 Elekta 111
      • 3.4.5.1 Prostate Cancer Treatment 111
    • 3.4.6 Ethicon 113
      • 3.4.6.1 Urinary Incontinence 113
    • 3.4.7 Karl Storz 115
      • 3.4.7.1 Stone Management 115
      • 3.4.7.2 Urological Endoscopes 117
    • 3.4.8 LABORIE 120
      • 3.4.8.1 Urodynamics 120
    • 3.4.9 Medline 122
      • 3.4.9.1 Urinary Incontinence 122
    • 3.4.10 Olympus 123
      • 3.4.10.1 Stone Management 123
      • 3.4.10.2 BPH Treatment 124
      • 3.4.10.3 Urological Endoscopes 125

JAPAN UROLOGICAL DEVICE MARKET OVERVIEW 127

  • 4.1 INTRODUCTION 127
  • 4.2 CURRENCY EXCHANGE RATE 129
  • 4.3 MARKET OVERVIEW 130
  • 4.4 TREND ANALYSIS BY SEGMENT 136
  • 4.5 DRIVERS AND LIMITERS 139
    • 4.5.1 Market Drivers 139
    • 4.5.2 Market Limiters 140
  • 4.6 COMPETITIVE MARKET SHARE ANALYSIS 143
  • 4.7 MERGERS AND ACQUISITIONS 150
  • 4.8 COMPANY PROFILES 152
    • 4.8.1 Boston Scientific 152
    • 4.8.2 C. R. Bard (Becton Dickinson) 154
    • 4.8.3 Coloplast 156
    • 4.8.4 Cook Medical 157
    • 4.8.5 Ethicon (Johnson & Johnson) 158
    • 4.8.6 Karl Storz 159
    • 4.8.7 LABORIE 160
    • 4.8.8 Olympus 161
  • 4.9 SWOT ANALYSIS 163
    • 4.9.1 Boston Scientific 164
    • 4.9.2 C. R. Bard (Becton Dickinson) 166
    • 4.9.3 Coloplast 168
    • 4.9.4 Cook Medical 169
    • 4.9.5 Ethicon (Johnson & Johnson) 171
    • 4.9.6 Karl Storz 172
    • 4.9.7 LABORIE 173
    • 4.9.8 Olympus 174

PROCEDURE NUMBERS 176

  • 5.1 PROCEDURE OVERVIEW 176
  • 5.2 URINARY INCONTINENCE PROCEDURES 181
    • 5.2.1 Male Incontinence Management Procedures 183
    • 5.2.2 Female Incontinence Management Procedures 185
  • 5.3 PELVIC ORGAN PROLAPSE REPAIR 188
  • 5.4 STONE MANAGEMENT PROCEDURES 190
    • 5.4.1 ESWL Procedures 193
    • 5.4.2 Transurethral Procedures 195
    • 5.4.3 Ureteral Stent Placement Procedures 197
    • 5.4.4 PCNL Procedures 199
  • 5.5 BPH PROCEDURES 201
  • 5.6 ERECTILE DYSFUNCTION MANAGEMENT PROCEDURES 204

URINARY INCONTINENCE MANAGEMENT DEVICE MARKET 207

  • 6.1 INTRODUCTION 207
  • 6.2 MARKET OVERVIEW 209
  • 6.3 MARKET ANALYSIS AND FORECAST 214
    • 6.3.1 Total Urinary Catheter Market 214
      • 6.3.1.1 Intermittent Catheter Market 217
      • 6.3.1.2 Foley Catheter Market 219
      • 6.3.1.3 Male External Catheter Market 221
    • 6.3.2 Urethral Bulking Agent 223
    • 6.3.3 Total Incontinence Management Device Market 224
      • 6.3.3.1 Total Female Incontinence Sling Market 227
      • 6.3.3.1.1 Transvaginal Tape Female Incontinence Sling Market 232
      • 6.3.3.1.2 Transobturator Female Incontinence Sling Market 234
      • 6.3.3.2 Total Male Implantable Incontinence Device Market 236
      • 6.3.3.2.1 Male Incontinence Sling Market 241
      • 6.3.3.2.2 Male Artificial Urinary Sphincter Market 243
  • 6.4 DRIVERS AND LIMITERS 245
    • 6.4.1 Market Drivers 245
    • 6.4.2 Market Limiters 245
  • 6.5 COMPETITIVE MARKET SHARE ANALYSIS 248

PELVIC ORGAN PROLAPSE REPAIR DEVICE MARKET 253

  • 7.1 INTRODUCTION 253
  • 7.2 MARKET OVERVIEW 255
  • 7.3 MARKET ANALYSIS AND FORECAST 260
    • 7.3.1 Total Pelvic Organ Prolapse Repair Device Market 260
    • 7.3.2 Transvaginal Mesh Market 263
    • 7.3.3 Sacrocolpopexy Mesh Market 265
  • 7.4 DRIVERS AND LIMITERS 267
    • 7.4.1 Market Drivers 267
    • 7.4.2 Market Limiters 267
  • 7.5 COMPETITIVE MARKET SHARE ANALYSIS 269

STONE MANAGEMENT DEVICE MARKET 272

  • 8.1 INTRODUCTION 272
  • 8.2 MARKET OVERVIEW 275
  • 8.3 MARKET ANALYSIS AND FORECAST 281
    • 8.3.1 ESWL Equipment Market 281
    • 8.3.2 ISWL Equipment Market 284
    • 8.3.3 Total Holmium Laser Market 286
      • 8.3.3.1 Holmium Laser Equipment Market 289
      • 8.3.3.2 Holmium Laser Fiber Market 291
    • 8.3.4 Total Stone Fragment Retrieval Device Market 294
      • 8.3.4.1 Nitinol Stone Fragment Retrieval Device Market 299
      • 8.3.4.2 Stainless Steel Stone Fragment Retrieval Device Market 301
    • 8.3.5 Ureteral Stent Market 303
    • 8.3.6 Ureteral Guidewire Market 305
  • 8.4 DRIVERS AND LIMITERS 307
    • 8.4.1 Market Drivers 307
    • 8.4.2 Market Limiters 308
  • 8.5 COMPETITIVE MARKET SHARE ANALYSIS 310

BPH TREATMENT DEVICE MARKET 316

  • 9.1 INTRODUCTION 316
    • 9.1.1 Treatments 317
    • 9.1.2 Comparison of TURP and Laser BPH Procedures 318
    • 9.1.3 Emerging Technologies 318
  • 9.2 MARKET OVERVIEW 320
  • 9.3 MARKET ANALYSIS AND FORECAST 325
    • 9.3.1 Total TURP Market 325
      • 9.3.1.1 Monopolar Electrode Market 328
      • 9.3.1.2 Bipolar Electrode Market 330
    • 9.3.2 Total Laser BPH Market 332
      • 9.3.2.1 Laser BPH Equipment Market 335
      • 9.3.2.2 Laser BPH Fiber Market 337
    • 9.3.3 UroLift® Market 339
    • 9.3.4 Rezum® Market 342
  • 9.4 DRIVERS AND LIMITERS 343
    • 9.4.1 Market Limiters 344
  • 9.5 COMPETITIVE MARKET SHARE ANALYSIS 347

ERECTILE DYSFUNCTION DEVICE MARKET 351

  • 10.1 INTRODUCTION 351
    • 10.1.1 Low Testosterone Pharmaceutical Delivery 352
  • 10.2 MARKET OVERVIEW 353
  • 10.3 MARKET ANALYSIS AND FORECAST 358
    • 10.3.1 Inflatable Erectile Dysfunction Device Market 358
    • 10.3.2 Malleable Erectile Dysfunction Device Market 360
    • 10.3.3 Vacuum Erectile Dysfunction Device 362
  • 10.4 DRIVERS AND LIMITERS 363
    • 10.4.1 Market Drivers 363
    • 10.4.2 Market Limiters 363
  • 10.5 COMPETITIVE MARKET SHARE ANALYSIS 365

ABBREVIATIONS 368

LIST OF CHARTS

  • Chart 1 1: Urological Device Market by Segment, Japan, 2016 - 2026 2
  • Chart 1 2: Urological Device Market by Segment, Japan, 2019 & 2026 2
  • Chart 4 1: Urological Device Market by Segment, Japan, 2016 - 2026 133
  • Chart 4 2: Urological Device Market Breakdown, Japan, 2019 134
  • Chart 4 3: Urological Device Market Breakdown, Japan, 2026 135
  • Chart 4 4: Growth Rates by Segment, Urological Device Market, Japan, 2017 - 2026 138
  • Chart 4 5: Urological Device Market, Japan, 2019 149
  • Chart 5 1: Urological Procedures by Type, Japan, 2016 - 2026 178
  • Chart 5 2: Urological Procedures by Type, Japan, 2019 179
  • Chart 5 3: Urological Procedures by Type, Japan, 2026 180
  • Chart 5 4: Urinary Incontinence Procedures by Type, Japan, 2016 - 2026 182
  • Chart 5 5: Male Incontinence Management Procedures by Type, Japan, 2016 - 2026 184
  • Chart 5 6: Female Incontinence Management Procedures by Type, Japan, 2016 - 2026 187
  • Chart 5 7: Pelvic Organ Prolapse Repair Procedures by Type, Japan, 2016 - 2026 189
  • Chart 5 8: Stone Management Procedures by Type, Japan, 2016 - 2026 192
  • Chart 5 9: ESWL Procedures, Japan, 2016 - 2026 194
  • Chart 5 10: Transurethral Procedures by Type, Japan, 2016 - 2026 196
  • Chart 5 11: Ureteral Stent Placement Procedures, Japan, 2016 - 2026 198
  • Chart 5 12: PCNL Procedures, Japan, 2016 - 2026 200
  • Chart 5 13: BPH Procedures by Type, Japan, 2016 - 2026 203
  • Chart 5 14: Erectile Dysfunction Management Procedures by Type, Japan, 2016 - 2026 206
  • Chart 6 1: Urinary Incontinence Management Device Market by Segment, Japan, 2016 - 2026 (US$M) 211
  • Chart 6 2: Urinary Incontinence Management Device Market by Segment, Japan, 2019 212
  • Chart 6 3: Urinary Incontinence Management Device Market by Segment, Japan, 2026 213
  • Chart 6 4: Urinary Catheter Market by Segment, Japan, 2016 - 2026 216
  • Chart 6 5: Intermittent Catheter Market, Japan, 2016 - 2026 218
  • Chart 6 6: Foley Catheter Market, Japan, 2016 - 2026 220
  • Chart 6 7: Male External Catheter Market, Japan, 2016 - 2026 222
  • Chart 6 8: Incontinence Management Device Market by Segment, Japan, 2016 - 2026 226
  • Chart 6 9: Female Incontinence Sling Market by Type, Japan, 2016 - 2026 229
  • Chart 6 10: Total Female Incontinence Sling Market, Japan, 2016 - 2026 231
  • Chart 6 11: Transvaginal Tape Female Incontinence Sling Market, Japan, 2016 - 2026 233
  • Chart 6 12: Transobturator Female Incontinence Sling Market, Japan, 2016 - 2026 235
  • Chart 6 13: Male Implantable Incontinence Device Market by Segment, Japan, 2015 - 2025 238
  • Chart 6 14: Total Male Implantable Incontinence Device Market, Japan, 2016 - 2026 240
  • Chart 6 15: Male Incontinence Sling Market, Japan, 2016 - 2026 242
  • Chart 6 16: Male Artificial Urinary Sphincter Market, Japan, 2016 - 2026 244
  • Chart 6 17: Leading Competitors, Urinary Incontinence Management Device Market, Japan, 2019 252
  • Chart 7 1: Pelvic Organ Prolapse Repair Device Market by Segment, Japan, 2016 - 2026 257
  • Chart 7 2: Pelvic Organ Prolapse Repair Device Market Breakdown, Japan, 2019 258
  • Chart 7 3: Pelvic Organ Prolapse Repair Device Market Breakdown, Japan, 2026 259
  • Chart 7 4: Pelvic Organ Prolapse Repair Device Market, Japan, 2016 - 2026 262
  • Chart 7 5: Transvaginal Mesh Market, Japan, 2016 - 2026 264
  • Chart 7 6: Sacrocolpopexy Mesh Market, Japan, 2016 - 2026 266
  • Chart 7 7: Leading Competitors, Pelvic Organ Prolapse Repair Market, Japan, 2019 271
  • Chart 8 1: Stone Management Device Market by Segment, Japan, 2016 - 2026 278
  • Chart 8 2: Stone Management Device Market Breakdown, Japan, 2019 279
  • Chart 8 3: Stone Management Device Market Breakdown, Japan, 2026 280
  • Chart 8 4: ESWL Equipment Market, Japan, 2016 - 2026 283
  • Chart 8 5: ISWL Equipment Market, Japan, 2016 - 2026 285
  • Chart 8 6: Holmium Laser Market by Segment, Japan, 2016 - 2026 288
  • Chart 8 7: Holmium Laser Equipment Market, Japan, 2016 - 2026 290
  • Chart 8 8: Holmium Laser Fiber Market, Japan, 2016 - 2026 293
  • Chart 8 9: Stone Fragment Retrieval Device Market by Segment, Japan, 2016 - 2026 296
  • Chart 8 10: Total Stone Fragment Retrieval Device Market, Japan, 2016 - 2026 298
  • Chart 8 11: Nitinol Stone Fragment Retrieval Device Market, Japan, 2016 - 2026 300
  • Chart 8 12: Stainless Steel Stone Fragment Retrieval Device Market, Japan, 2016 - 2026 302
  • Chart 8 13: Ureteral Stent Market, Japan, 2016 - 2026 304
  • Chart 8 14: Ureteral Guidewire Market, Japan, 2016 - 2026 306
  • Chart 8 15: Leading Competitors, Stone Management Device Market, Japan, 2019 315
  • Chart 9 1: BPH Treatment Device Market by Segment, Japan, 2016 - 2026 322
  • Chart 9 2: BPH Treatment Device Market Breakdown, Japan, 2019 323
  • Chart 9 3: BPH Treatment Device Market Breakdown, Japan, 2026 324
  • Chart 9 4: TURP Market by Segment, Japan, 2016 - 2026 327
  • Chart 9 5: Monopolar Electrode Market, Australia, 2016 - 2026 329
  • Chart 9 6: Bipolar Electrode Market, Japan, 2016 - 2026 331
  • Chart 9 7: Laser BPH Market by Segment, Japan, 2016 - 2026 334
  • Chart 9 8: Laser BPH Equipment Market, Japan, 2016 - 2026 336
  • Chart 9 9: Laser BPH Fiber Market by Segment, Japan, 2016 - 2026 338
  • Chart 9 10: UroLift Market, Japan, 2016 - 2026 341
  • Chart 9 11: Leading Competitors, BPH Device Market, Japan, 2019 350
  • Chart 10 1: Erectile Dysfunction Device Market by Segment, Japan, 2016 - 2026 355
  • Chart 10 2: Erectile Dysfunction Device Market Breakdown, Japan, 2019 356
  • Chart 10 3: Erectile Dysfunction Device Market Breakdown, Japan, 2026 357
  • Chart 10 4: Inflatable Erectile Dysfunction Device Market, Japan, 2016 - 2026 359
  • Chart 10 5: Malleable Erectile Dysfunction Device Market, Japan, 2016 - 2026 361
  • Chart 10 6: Leading Competitors, Erectile Dysfunction Device Market, Japan, 2019 367

LIST OF FIGURES

  • Figure 1 1: Urological Device Market Share Ranking by Segment, Japan, 2019 3
  • Figure 1 2: Companies Researched in this Report, Japan, 2019 4
  • Figure 1 3: Factors Impacting the Urological Device Market by Segment, Japan 5
  • Figure 1 4: Recent Events in the Urological Device Market, 2017 - 2019 (1 of 2) 6
  • Figure 1 5: Recent Events in the Urological Device Market, 2017 - 2019 (2 of 2) 7
  • Figure 1 6: Urological Procedures Covered, Japan 8
  • Figure 1 7: Urological Device Markets Covered, Japan (1 of 2) 9
  • Figure 1 8: Urological Device Markets Covered, Japan (2 of 2) 10
  • Figure 1 9: Key Report Updates 11
  • Figure 1 10: Version History 11
  • Figure 3 1: Urinary Incontinence Treatments by Company (1 of 3) 55
  • Figure 3 2: Urinary Incontinence Treatments by Company (2 of 3) 56
  • Figure 3 3: Urinary Incontinence Treatments by Company (3 of 3) 57
  • Figure 3 4: Stone Management Devices by Company (1 of 3) 64
  • Figure 3 5: Stone Management Devices by Company (2 of 3) 65
  • Figure 3 6: Stone Management Devices by Company (3 of 3) 66
  • Figure 3 7: BPH Treatments by Company 75
  • Figure 3 8: Erectile Dysfunction Devices by Company 78
  • Figure 3 9: Class 2 Device Recall Auriga Laser System 79
  • Figure 3 10: Class 2 Device Recall Fiber Strippers and Cleavers 80
  • Figure 3 11: Class 2 Device Recall StarMedTec LightTrail Reusable Fibers 81
  • Figure 3 12: Class 2 Device Recall Malecot Catheter Set 81
  • Figure 3 13: Class 2 Device Recall Encore(TM) 26 Inflation Device 81
  • Figure 3 14: Class 2 Device Recall Bardex Lubricath 3Way 75cc Continuous Irrigation Foley Catheter 82
  • Figure 3 15: Class 2 Device Recall Intermittent Catheters 82
  • Figure 3 16: Class 2 Device Recall leg bag 82
  • Figure 3 17: Class 2 Device Recall SURESTEP 83
  • Figure 3 18: Class 2 Device Recall PureWick External Catheter 83
  • Figure 3 19: Class 2 Device Recall SURESTEP Tray, BARDEX I.C. COMPLETE CARE, Urine Meter, Temperature STATLOCK Stabilization Device 83
  • Figure 3 20: Class 2 Device Recall BARD Irrigation Syringe, Rx Only, Sterile 84
  • Figure 3 21: Class 2 Device Recall Magic3 84
  • Figure 3 22: Class 2 Device Recall Optionvm Urinary Catheter. Male use only. Latex Free. Sterile, Rx only. 84
  • Figure 3 23: Class 3 Device Recall SureStep Tray, with AddaFoley 85
  • Figure 3 24: Class 2 Device Recall BARDEX 85
  • Figure 3 25: Class 3 Device Recall BARD Toomey Irrigation Syringe 70cc 85
  • Figure 3 26: Class 3 Device Recall Antibacterial Hydro Personal Catheter 85
  • Figure 3 27: Class 2 Device Recall Magic3 Intermittent Catheter with Sure Grip Hydrophilic Coated Silicone Coude tip 86
  • Figure 3 28: Class 2 Device Recall Magic3 Hydrophiliccoated Female Intermittent Catheter 86
  • Figure 3 29: Class 2 Device Recall Bard 100 LatexFree Urinary Drainage Bag with AntiReflux Chamber and Bard EXLok Sampling 86
  • Figure 3 30: Class 2 Device Recall Bard Dimension Stone Basket 87
  • Figure 3 31: Class 2 Device Recall CMax 87
  • Figure 3 32: Class 2 Device Recall Bard BrachySource Seed Implants 87
  • Figure 3 33: Class 2 Device Recall I125 CE Marked QuickLink Cartridges 88
  • Figure 3 34: Class 2 Device Recall Bard 88
  • Figure 3 35: Class 2 Device Recall XForce Nephrostomy Balloon Dilation Catheter Kit with Inflation Device 89
  • Figure 3 36: Class 2 Device Recall SelfCath Pediatric Catheter 90
  • Figure 3 37: Class 2 Device Recall Coloplast Conveen Urine Collection Leg Bag 90
  • Figure 3 38: Class 2 Device Recall Genesis Malleable Penile Prosthesis 90
  • Figure 3 39: Class 2 Device Recall StoneBreaker 91
  • Figure 3 40: Class 2 Device Recall OptiLite MultiUse Holmium Laser Fibers 91
  • Figure 3 41: Class 2 Device Recall Cook MultiUse Holmium Laser Fibers 92
  • Figure 3 42: Class 2 Device Recall Cook Bush 92
  • Figure 3 43: Class 2 Device Recall Aprima" Access Nonvascular Introducer Set 92
  • Figure 3 44: Class 2 Device Recall Ascend AQ 93
  • Figure 3 45: Class 2 Device Recall Oncentra Brachy 4.5 94
  • Figure 3 46: Class 2 Device Recall Oncentra External Beam Treatment Planning Software 94
  • Figure 3 47: Class 2 Device Recall Oncentra External Beam Treatment Planning Software 94
  • Figure 3 48: Class 2 Device Recall Oncentra Brachy treatment planning system 94
  • Figure 3 49: Class 2 Device Recall STORZ High Flow Insufflation Tubing (with filter) 95
  • Figure 3 50: Class 2 Device Recall Image1 SPIES XLINK Camera Control Unit (CCU) 95
  • Figure 3 51: Class 2 Device Recall Ureteroreno Videoscope & Fiberscope 96
  • Figure 3 52: Class 2 Device Recall A20975A: Working insert, with ramp, one way; A20976A: Bridge, one way; A20977A; Bridge, two way 96
  • Figure 3 53: Class 2 Device Recall Olympus High Freqency Resection Electrodes 96
  • Figure 3 54: Class 2 Device Recall Ureteroreno videoscope URFV2 and URFV2R 97
  • Figure 3 55: Class 2 Device Recall HF Cable WA00014A 97
  • Figure 3 56: Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence (Solyx) 98
  • Figure 3 57: Mid-Urethral Sling Tensioning Trial (MUST) 98
  • Figure 3 58: Prospective Registry for Patients Undergoing Surgery for Male Stress Urinary Incontinence 99
  • Figure 3 59: Stop or Ongoing Oral Anticoagulation in Patients Undergoing Pvp (SOAP) (SOAP) 99
  • Figure 3 60: LithoVue Single Use Disposable Ureteroscope 100
  • Figure 3 61: Comparing Treatment of Urolithiasis Between Disposable and Reusable Ureteroscope 100
  • Figure 3 62: Indwelling Stent Discoloration Project 101
  • Figure 3 63: Reduction of Stent Associated Morbidity by Minimizing Stent Material. 101
  • Figure 3 64: PROPPER Prospective Registry of Outcomes With Penile Prosthesis (PROPPER) 102
  • Figure 3 65: Patient Satisfaction During Outpatient Versus Inpatient Foley Catheter Induction of Labor 103
  • Figure 3 66: Foley Catheter vs a Self-contained Valved Urinary Catheter 103
  • Figure 3 67: Bladder Morphology Using 2 Different Catheter Designs 104
  • Figure 3 68: Outpatient Labor Induction With the Transcervical Foley Balloon 104
  • Figure 3 69: Medical and Economic Evaluation for Intermediate-risk Prostate Cancer (GETUGP05) 105
  • Figure 3 70: Detection of Clinically Significant Prostate Cancer Using Transperineal Targeted Biopsy Compared to Standard Transrectal Biopsy 105
  • Figure 3 71: Product Evaluation of a Newly Developed Intermittent Catheter. 106
  • Figure 3 72: Clinical Study Investigating Safety and Performance of a New Urinary Intermittent Catheter in Healthy Volunteers 106
  • Figure 3 73: Clinical Study Investigating Safety and Performance of a New Urinary Intermittent Catheters in Healthy Volunteers 106
  • Figure 3 74: Virtue® European Study 107
  • Figure 3 75: Exploratory Study Investigating Urodynamic Parameters During Catheterisation 107
  • Figure 3 76: Altis® 522 Trial - Treatment of Female Stress Urinary Incontinence 107
  • Figure 3 77: The European Study of Altis Single Incision Sling System for Female Stress Urinary Incontinence (EASY) 108
  • Figure 3 78: Do Hydrophilic Catheters Decrease Pain and Discomfort of a Patient During Urodynamic Study (HYDRUDS) 108
  • Figure 3 79: Efficacy Study of Antimicrobial Catheters to Avoid Urinary Infections in Spinal Cord Injured Patients (ESCALE) 108
  • Figure 3 80: Ureteral Stent Study 109
  • Figure 3 81: Impact Ureteral Sheath Design During Ureteroscopy 109
  • Figure 3 82: Optimization of Ureterolysis During Hysterectomy 110
  • Figure 3 83: Suctioning Flexible Ureteroscopy With Intelligent Control of Renal Pelvic Pressure 110
  • Figure 3 84: Evaluation Of Transperineal Ultrasound For Image Guidance In The Treatment Of Prostate Cancer in Men Following Prostatectomy 111
  • Figure 3 85: Use of Non-invasive 4D Ultrasound Clarity System in Prostate IMRT/RapidArc Therapy 111
  • Figure 3 86: Single Fraction Real-time High-Dose-Rate Brachytherapy in Patients With Low and Intermediate Risk Prostate Cancer (SINFRA_PROST) 112
  • Figure 3 87: Dose Escalation to Dominant Intraprostatic Lesions (DIL) With MRI-TRUS Fusion High Dose Rate (HDR) Prostate Brachytherapy (BRAPROST) 112
  • Figure 3 88: Combined Treatment for Mixed Incontinence (ESTEEM) 113
  • Figure 3 89: TVT-ABBREVO Versus SERASIS for the Treatment of Female Urinary Stress Incontinence: 1 Year Outcomes of a Comparative Study With 2 Trans-obturator Sub Mid Urethral Slings 113
  • Figure 3 90: Trans-obturator Mid-urethral Sling and the Single-incision Sling in Women With Stress Urinary Incontinence 114
  • Figure 3 91: Low-energy Extracorporeal Shockwave Treatment for Patients After Radical Prostatectomy 115
  • Figure 3 92: Low-Intensity Extracorporeal Shockwave Therapy and Vacuum Erectile Device as a Treatment for Peyronies Disease 115
  • Figure 3 93: Safety and Effect of Low-Energy Extracorporeal Shockwave Therapy (ESWT) on the Renal Allograft in Transplant Recipients. 116
  • Figure 3 94: Low Energy Shockwave Therapy (LE-SWT): A Novel Treatment for Chronic Kidney Disease 116
  • Figure 3 95: Narrow Versus Wide Focal Zones for Shock Wave Lithotripsy of Renal Calculi 116
  • Figure 3 96: Are the Stone Density and Location Useful Parameters for Small Kidney Stones? 117
  • Figure 3 97: Durability of Flexible Ureteroscopes and Causes of Infection During Flexible Ureterorenoscopy 117
  • Figure 3 98: Comparison of Different Energy Sources During TUR-P 117
  • Figure 3 99: Effects of Flexible Ureteroscopy on Renal Blood Flow 118
  • Figure 3 100: A Study of Blue Light Flexible Cystoscopy With Cysview in the Detection of Bladder Cancer in the Surveillance Setting 118
  • Figure 3 101: Blue Light Cystoscopy With Cysview® Registry (BLCCR) 118
  • Figure 3 102: Safety Study of Bipolar Versus Monopolar Transurethral Resection of Bladder Tumors 119
  • Figure 3 103: Multi-Center Comparison of Dual Lumen Versus Single Lumen Ureteroscopes 119
  • Figure 3 104: T-DOC® 5 Fr Pediatric Clinical Investigation 120
  • Figure 3 105: Air vs Water Catheters (AvW (Bonn)) 120
  • Figure 3 106: A Human Factor Study To Asses The Usability And Feasibility Of The Peritron+ During Intended Use 120
  • Figure 3 107: Portable Pves Study 121
  • Figure 3 108: Ambulatory Pessary Trial 121
  • Figure 3 109: Study to Compare CAUTI Rates Following ERASE CAUTI Tray Non-Silver vs Silver Coated Foley Catheters 122
  • Figure 3 110: Study to Compare CAUTI Rates Following ERASE CAUTI Tray Silver vs Silver Coated Foley Catheters 122
  • Figure 3 111: Trial Comparing Three Different Devices for Kidney Stone Removal During Percutaneous Surgery 123
  • Figure 3 112: Quality of Life in Kidney Stone Patients Undergoing Surgery 123
  • Figure 3 113: Prostate Vaporization Techniques in Canadian Hospital 124
  • Figure 3 114: Treatment of Symptomatic BPH Patients Undergoing Anticoagulant Therapy Using the PlasmaButton Vaporization Electrode 124
  • Figure 3 115: Assessment of Infection Control, Practice Efficiency, and Health Economics of Sheathed Versus Standard Cystoscopy 125
  • Figure 3 116: Results of Safety Guidewire Use in Ureteroscopic Stone Surgery 125
  • Figure 3 117: Transurethral En Bloc Versus Standard Resection of Bladder Tumour 125
  • Figure 3 118: PlasmaKinetic (PK) Button Vaporization Electrode for Treatment of Bladder Tumors (PK Button) 126
  • Figure 4 1: Currency Exchange Rate, 2019 129
  • Figure 4 2: Urological Device Market by Segment, Japan, 2016 - 2026 (US$M) 131
  • Figure 4 3: Urological Device Market by Segment, Japan, 2016 - 2026 (JP¥M) 132
  • Figure 4 4: Urological Device Market Growth by Segment, Japan, 2016 - 2026 137
  • Figure 4 5: Drivers and Limiters, Urological Device Market, Japan, 2019 142
  • Figure 4 6: Leading Competitors, Urological Device Market, Japan, 2019 148
  • Figure 4 7: SWOT Analysis, Boston Scientific (1 of 2) 164
  • Figure 4 8: SWOT Analysis, Boston Scientific (2 of 2) 165
  • Figure 4 9: SWOT Analysis, C. R. Bard (Becton Dickinson) (1 of 2) 166
  • Figure 4 10: SWOT Analysis, C. R. Bard (Becton Dickinson) (2 of 2) 167
  • Figure 4 11: SWOT Analysis, Coloplast 168
  • Figure 4 12: SWOT Analysis, Cook Medical (1 of 2) 169
  • Figure 4 13: SWOT Analysis, Cook Medical (2 of 2) 170
  • Figure 4 14: SWOT Analysis, Ethicon (Johnson & Johnson) 171
  • Figure 4 15: SWOT Analysis, Karl Storz 172
  • Figure 4 16: SWOT Analysis, LABORIE 173
  • Figure 4 17: SWOT Analysis, Olympus (1 of 2) 174
  • Figure 4 18: SWOT Analysis, Olympus (2 of 2) 175
  • Figure 5 1: Urological Procedures by Type, Japan, 2016 - 2026 177
  • Figure 5 2: Urinary Incontinence Procedures by Type, Japan, 2016 - 2026 181
  • Figure 5 3: Male Incontinence Management Procedures by Type, Japan, 2016 - 2026 183
  • Figure 5 4: Female Incontinence Management Procedures by Type, Japan, 2016 - 2026 186
  • Figure 5 5: Pelvic Organ Prolapse Repair Procedures by Type, Japan, 2016 - 2026 188
  • Figure 5 6: Stone Management Procedures by Type, Japan, 2016 - 2026 191
  • Figure 5 7: ESWL Procedures, Japan, 2016 - 2026 193
  • Figure 5 8: Transurethral Procedures by Type, Japan, 2016 - 2026 195
  • Figure 5 9: Ureteral Stent Placement Procedures, Japan, 2016 - 2026 197
  • Figure 5 10: PCNL Procedures, Japan, 2016 - 2026 199
  • Figure 5 11: BPH Procedures by Type, Japan, 2016 - 2026 202
  • Figure 5 12: Erectile Dysfunction Management Procedures by Type, Japan, 2016 - 2026 205
  • Figure 6 1: Urinary Incontinence Management Device Market by Segment, Japan, 2016 - 2026 (US$M) 210
  • Figure 6 2: Urinary Incontinence Management Device Market by Segment, Japan, 2016 - 2026 (JP¥M) 210
  • Figure 6 3: Urinary Catheter Market by Segment, Japan, 2016 - 2026 (US$M) 215
  • Figure 6 4: Urinary Catheter Market by Segment, Japan, 2016 - 2026 (JP¥M) 215
  • Figure 6 5: Intermittent Catheter Market, Japan, 2016 - 2026 217
  • Figure 6 6: Foley Catheter Market, Japan, 2016 - 2026 219
  • Figure 6 7: Male External Catheter Market, Japan, 2016 - 2026 221
  • Figure 6 8: Incontinence Management Device Market by Segment, Japan, 2016 - 2026 (US$M) 225
  • Figure 6 9: Incontinence Management Device Market by Segment, Japan, 2016 - 2026 (JP¥M) 225
  • Figure 6 10: Female Incontinence Sling Market by Type, Japan, 2016 - 2026 (US$M) 228
  • Figure 6 11: Female Incontinence Sling Market by Type, Japan, 2016 - 2026 (JP¥M) 228
  • Figure 6 12: Total Female Incontinence Sling Market, Japan, 2016 - 2026 230
  • Figure 6 13: Transvaginal Tape Female Incontinence Sling Market, Japan, 2016 - 2026 232
  • Figure 6 14: Transobturator Female Incontinence Sling Market, Japan, 2016 - 2026 234
  • Figure 6 15: Male Implantable Incontinence Device Market by Segment, U.S., 2015 - 2025 (US$M) 237
  • Figure 6 16: Male Implantable Incontinence Device Market by Segment, U.S., 2015 - 2025 (JP¥M) 237
  • Figure 6 17: Total Male Implantable Incontinence Device Market, Japan, 2016 - 2026 239
  • Figure 6 18: Male Incontinence Sling Market, Japan, 2016 - 2026 241
  • Figure 6 19: Male Artificial Urinary Sphincter Market, Japan, 2016 - 2026 243
  • Figure 6 20: Drivers and Limiters, Urinary Incontinence Management Device Market, Japan, 2019 247
  • Figure 6 21: Leading Competitors, Urinary Incontinence Management Device Market, Japan, 2018 251
  • Figure 7 1: Pelvic Organ Prolapse Repair Device Market by Segment, Japan, 2016 - 2026 (US$M) 256
  • Figure 7 2: Pelvic Organ Prolapse Repair Device Market by Segment, Japan, 2016 - 2026 (JP¥M) 256
  • Figure 7 3: Total Pelvic Organ Prolapse Repair Device Market, Japan, 2016 - 2026 261
  • Figure 7 4: Transvaginal Mesh Market, Australia, 2013 - 2023 263
  • Figure 7 5: Sacrocolpopexy Mesh Market, Japan, 2016 - 2026 265
  • Figure 7 6: Drivers and Limiters, Pelvic Organ Prolapse Repair Market, Japan, 2019 268
  • Figure 7 7: Leading Competitors, Pelvic Organ Prolapse Repair Market, Japan, 2019 270
  • Figure 8 1: Stone Management Device Market by Segment, Japan, 2016 - 2026 (US$M) 276
  • Figure 8 2: Stone Management Device Market by Segment, Japan, 2016 - 2026 (JP¥M) 277
  • Figure 8 3: ESWL Equipment Market, Japan, 2016 - 2026 282
  • Figure 8 4: ISWL Equipment Market, Japan, 2016 - 2026 284
  • Figure 8 5: Holmium Laser Market by Segment, Japan, 2016 - 2026 (US$M) 286
  • Figure 8 6: Holmium Laser Market by Segment, Japan, 2016 - 2026 (JP¥M) 287
  • Figure 8 7: Holmium Laser Equipment Market, Japan, 2016 - 2026 289
  • Figure 8 8: Holmium Laser Fiber Market, Japan, 2016 - 2026 292
  • Figure 8 9: Stone Fragment Retrieval Device Market by Segment, Japan, 2016 - 2026 (US$M) 295
  • Figure 8 10: Stone Fragment Retrieval Device Market by Segment, Japan, 2016 - 2026 (JP¥M) 295
  • Figure 8 11: Total Stone Fragment Retrieval Device Market, Japan, 2016 - 2026 297
  • Figure 8 12: Nitinol Stone Fragment Retrieval Device Market, Japan, 2016 - 2026 299
  • Figure 8 13: Stainless Steel Stone Fragment Retrieval Device Market, Japan, 2016 - 2026 301
  • Figure 8 14: Ureteral Stent Market, Japan, 2016 - 2026 303
  • Figure 8 15: Ureteral Guidewire Market, Japan, 2016 - 2026 305
  • Figure 8 16: Drivers and Limiters, Stone Management Device Market, Japan, 2018 309
  • Figure 8 17: Leading Competitors, Stone Management Device Market, Japan, 2019 314
  • Figure 9 1: BPH Treatment Device Market by Segment, Japan, 2016 - 2026 (US$M) 321
  • Figure 9 2: BPH Treatment Device Market by Segment, Japan, 2016 - 2026 (JP¥M) 321
  • Figure 9 3: TURP Market by Segment, Japan, 2016 - 2026 (US$M) 326
  • Figure 9 4: TURP Market by Segment, Japan, 2016 - 2026 (JP¥M) 326
  • Figure 9 5: Monopolar Electrode Market, Japan, 2016 - 2026 328
  • Figure 9 6: Bipolar Electrode Market, Japan, 2016 - 2026 330
  • Figure 9 7: Laser BPH Market by Segment, Japan, 2016 - 2026 (US$M) 333
  • Figure 9 8: Laser BPH Market by Segment, Japan, 2016 - 2026 (JP¥M) 333
  • Figure 9 9: Laser BPH Equipment Market, Japan, 2016 - 2026 335
  • Figure 9 10: Laser BPH Fiber Market, Japan, 2016 - 2026 337
  • Figure 9 11: UroLift Market, Japan, 2016 - 2026 340
  • Figure 9 12: Drivers and Limiters, BPH Treatment Device Market, Australia, 2018 346
  • Figure 9 13: Leading Competitors, BPH Device Market, Japan, 2019 349
  • Figure 10 1: Erectile Dysfunction Device Market by Segment, Japan, 2016 - 2026 (US$M) 354
  • Figure 10 2: Erectile Dysfunction Device Market by Segment, Japan, 2016 - 2026 (JP¥M) 354
  • Figure 10 3: Inflatable Erectile Dysfunction Device Market, Japan, 2016 - 2026 358
  • Figure 10 4: Malleable Erectile Dysfunction Device Market, Japan, 2016 - 2026 360
  • Figure 10 5: Drivers and Limiters, Erectile Dysfunction Device Market, Japan, 2019 364
  • Figure 10 6: Leading Competitors, Erectile Dysfunction Device Market, Japan, 2019 366